Survival AnalysisSurvival RateCell SurvivalKaplan-Meier EstimateDisease-Free SurvivalPrognosisProportional Hazards ModelsSurvivalRetrospective StudiesTreatment OutcomeFollow-Up StudiesTime FactorsNeoplasm StagingGraft SurvivalMultivariate AnalysisRisk FactorsCohort StudiesTumor Markers, BiologicalProspective StudiesImmunohistochemistryBreast NeoplasmsPredictive Value of TestsAge FactorsNeoplasm Recurrence, LocalRegistriesLife TablesDisease ProgressionLung NeoplasmsLymphatic MetastasisCombined Modality TherapyAdenocarcinomaAntineoplastic Combined Chemotherapy ProtocolsRecurrenceRisk AssessmentIncidenceTissue Array AnalysisLiver NeoplasmsBrain NeoplasmsChemotherapy, AdjuvantProsthesis FailureCarcinoma, Squamous CellCarcinomaNeoplasm GradingColorectal NeoplasmsNeoplasm MetastasisGene Expression Regulation, NeoplasticRegression AnalysisApoptosisReoperationAntineoplastic AgentsStomach NeoplasmsNeoplasm InvasivenessLongitudinal StudiesOvarian NeoplasmsCarcinoma, Non-Small-Cell LungSex FactorsModels, StatisticalUnited StatesSEER ProgramBiostatisticsNeoplasmsLongevityCause of DeathCell Line, TumorAnalysis of VarianceChi-Square DistributionProbabilityCarcinoma, HepatocellularKi-67 AntigenGlioblastomaRadiotherapy, AdjuvantAge of OnsetKidney Failure, ChronicGene Expression ProfilingRiskMelanomaSeverity of Illness IndexActuarial AnalysisCannibalismSignal TransductionEsophageal NeoplasmsPostoperative ComplicationsMortalityMutationStrongylidaCell ProliferationCisplatinPancreatic NeoplasmsKidney TransplantationCementationNeoadjuvant TherapyCyclophosphamideComorbidityHip ProsthesisFluorouracilImmunoenzyme TechniquesReceptor, erbB-2Treatment FailureTumor Suppressor Protein p53Drug Administration Schedule